Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/118979

Beta release

Statistics of Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0800
2024-0900
2024-1000